PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32032847-0	2020	Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.	pyrimidine	43-53	matrix metallopeptidase 10	Homo sapiens	97-127	
32032847-5	2020	Starting with a lead fused pyrimidine-based MMP-13 inhibitor with weak MMP-10 inhibition, a structure-based design of pyrimidine and fused pyrimidine scaffolds was rationalized to enhance activity against MMP-10 in parallel with MMP-13.	pyrimidine	27-37	matrix metallopeptidase 10	Homo sapiens	205-211	
32032847-5	2020	Starting with a lead fused pyrimidine-based MMP-13 inhibitor with weak MMP-10 inhibition, a structure-based design of pyrimidine and fused pyrimidine scaffolds was rationalized to enhance activity against MMP-10 in parallel with MMP-13.	pyrimidine	118-128	matrix metallopeptidase 10	Homo sapiens	205-211	
32032847-5	2020	Starting with a lead fused pyrimidine-based MMP-13 inhibitor with weak MMP-10 inhibition, a structure-based design of pyrimidine and fused pyrimidine scaffolds was rationalized to enhance activity against MMP-10 in parallel with MMP-13.	pyrimidine	118-128	matrix metallopeptidase 10	Homo sapiens	205-211